Pages that link to "Q35965204"

The following pages link to Gut microbiota composition and relapse risk in pediatric MS: A pilot study (Q35965204):

Displaying 45 items.

• The Gut Microbiota in Immune-Mediated Inflammatory Diseases (Q26741414) (← links)
• Microbiota and neurologic diseases: potential effects of probiotics (Q28076752) (← links)
• The gut microbiome in human neurological disease: A review (Q30490923) (← links)
• Mucosal biopsy shows immunologic changes of the colon in patients with early MS (Q33799934) (← links)
• Associations between the gut microbiota and host immune markers in pediatric multiple sclerosis and controls (Q36139341) (← links)
• Metagenomic Investigation of Plasma in Individuals with ME/CFS Highlights the Importance of Technical Controls to Elucidate Contamination and Batch Effects (Q36180321) (← links)
• Alterations of the human gut microbiome in multiple sclerosis. (Q37060934) (← links)
• Emerging Approaches for Validating and Managing Multiple Sclerosis Relapse (Q37729523) (← links)
• Environmental modifiable risk factors for multiple sclerosis: Report from the 2016 ECTRIMS focused workshop (Q38663577) (← links)
• Evaluating the association of allergies with multiple sclerosis susceptibility risk and disease activity in a pediatric population (Q38893094) (← links)
• Breaking down the gut microbiome composition in multiple sclerosis (Q39036835) (← links)
• Clinical Evidence for the Microbiome in Inflammatory Diseases (Q39265428) (← links)
• Gut-CNS-Axis as Possibility to Modulate Inflammatory Disease Activity-Implications for Multiple Sclerosis (Q39434933) (← links)
• Modulation of Multiple Sclerosis and Its Animal Model Experimental Autoimmune Encephalomyelitis by Food and Gut Microbiota (Q41453198) (← links)
• Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models. (Q42221329) (← links)
• The multiple sclerosis microbiome? (Q42319826) (← links)
• The Role of the Gut Microbiome in Multiple Sclerosis Risk and Progression: Towards Characterization of the "MS Microbiome". (Q46181413) (← links)
• The Gut Microbiota and Pediatric Multiple Sclerosis: Recent Findings (Q46635710) (← links)
• Gut microbiome in multiple sclerosis: The players involved and the roles they play. (Q47100520) (← links)
• Immunological and Clinical Effect of Diet Modulation of the Gut Microbiome in Multiple Sclerosis Patients: A Pilot Study (Q47102802) (← links)
• The Gut Microbiome in Neuromyelitis Optica (Q47252742) (← links)
• Western lifestyle and immunopathology of multiple sclerosis (Q47639897) (← links)
• Gut microbiome and pediatric multiple sclerosis (Q47747875) (← links)
• Nature, nurture, and microbes: The development of multiple sclerosis (Q48001628) (← links)
• The "Gut Feeling": Breaking Down the Role of Gut Microbiome in Multiple Sclerosis (Q48047320) (← links)
• A gut feeling about multiple sclerosis (Q49647134) (← links)
• An introduction to the microbiome and MS. (Q50146314) (← links)
• Gut Microbiota in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis: Current Applications and Future Perspectives. (Q55236740) (← links)
• Focus on the gut-brain axis: Multiple sclerosis, the intestinal barrier and the microbiome (Q57482219) (← links)
• Altered tryptophan metabolism is associated with pediatric multiple sclerosis risk and course (Q57821114) (← links)
• A Scoping Review of Modifiable Risk Factors in Pediatric Onset Multiple Sclerosis: Building for the Future (Q58113232) (← links)
• Emerging Role of Diet and Microbiota Interactions in Neuroinflammation (Q58750497) (← links)
• Bacteria-Host Interactions in Multiple Sclerosis (Q60046896) (← links)
• Social-Stress-Responsive Microbiota Induces Stimulation of Self-Reactive Effector T Helper Cells (Q64056457) (← links)
• , A Human Gut Commensal, Is as Potent as COPAXONE® in an Animal Model of Multiple Sclerosis (Q64060902) (← links)
• Dietary Modulation of Intestinal Microbiota: Future Opportunities in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis (Q64108334) (← links)
• Evidence of Clostridium perfringens epsilon toxin associated with multiple sclerosis (Q64330488) (← links)
• The intestinal barrier in multiple sclerosis: implications for pathophysiology and therapeutics (Q88961131) (← links)
• Gut-brain communication in demyelinating disorders (Q89744997) (← links)
• The Gut Microbiota in Multiple Sclerosis: An Overview of Clinical Trials (Q90072442) (← links)
• Gut Microbiome in Inflammatory Bowel Disease and Other Chronic Immune-Mediated Inflammatory Diseases (Q90301486) (← links)
• Gut Microbiota in Neurological Disorders (Q90442587) (← links)
• The progress of gut microbiome research related to brain disorders (Q92735130) (← links)
• Alterations in Circulating Fatty Acid Are Associated With Gut Microbiota Dysbiosis and Inflammation in Multiple Sclerosis (Q98177691) (← links)
• Maternal dietary omega-3 deficiency worsens the deleterious effects of prenatal inflammation on the gut-brain axis in the offspring across lifetime (Q98384887) (← links)